AU
UK
CA
NZ
IND
US
-Copy_04_09_2026_21_06_37_639560.jpg)
BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) is a global biotechnology firm dedicated to converting genetic insights into targeted treatments for rare and severe disorders. The company commercializes eight key products, including Vimizim, Naglazyme, Palynziq, Brineura, Aldurazyme, Roctavian, Kuvan, and Voxzogo, addressing conditions such as lysosomal storage disorders, phenylketonuria, achondroplasia, and severe hemophilia A. Roctavian is a gene therapy aimed at restoring factor VIII levels in hemophilia A patients, while Voxzogo focuses on growth-related disorders. In addition, BioMarin has a broad clinical and preclinical pipeline featuring programs such as Vosoritide, BMN 333, BMN 390, BMN 351, BMN 349, and INZ-701, with INZ-701 positioned as a late-stage enzyme replacement therapy for ENPP1 deficiency.
As per US Inflation Report published on ‘BMRN’ on Feb 27, 2026, Kalkine provided an ‘Buy’ stance on the stock at USD 61.11 based on fundamental analysis.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...